Conditions: Alzheimer's Disease
Keywords: Agitation Aggression patients
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 350
Healthy volunteers: no

Brief summary:
The primary purpose of this study is to determine whether ELND005 is effective in treating symptoms of agitation and aggression in patients with Alzheimer's disease

Detailed description:

Arms:
arm 1: ELND005 film coated tablets, BID for 12 weeks arm 2: Matched placebo BID for 12 weeks

Interventions: intervention 1: ELND005 intervention 2: Placebo
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: